N-[3β-hydroxy-lup-20(29)-en-28-oyl]-8-aminooctanoic acid | 150840-29-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: N-[3β-hydroxy-lup-20(29)-en-28-oyl]-8-aminooctanoic acid
• 英文别名: Octanoic acid, 8-(((3beta)-3-hydroxy-28-oxolup-20(29)-en-28-yl)amino)-；8-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carbonyl]amino]octanoic acid
• CAS: 150840-29-2
• 化学式: C₃₈H₆₃NO₄
• 分子量: 597.923
• InChiKey: BBBZHWUAVJQHOG-HFQKFOCCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.6
• 重原子数：
  43
• 可旋转键数：
  10
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  86.6
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[3β-hydroxy-lup-20(29)-en-28-oyl]-8-aminooctanoic acid 在 sodium hydroxide 、 1-羟基苯并三唑 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 生成 N-[N-[3-beta-Hydroxy-20(29)-en-28-oyl]-8-aminooctanoyl]-L-leucine
  参考文献：
  名称：

  抗艾滋病毒药物49.基于桦木酸的IC9564类似物的合成，抗HIV和抗融合活性。

  摘要：

  桦木酸衍生物IC9564抑制人免疫缺陷病毒（HIV）-1的进入。在一系列IC9564衍生物中，有5种和20种是最有希望的抗HIV感染化合物，其EC（50）值分别为0.33和0.46 microM。两种化合物抑制合胞体形成与EC（50）值分别为0.40和0.33 microM。两种测定法中可比较的EC（50）值表明，这些化合物是融合抑制剂。结构-活性关系数据还表明，可以消除IC9564中的双键，并且可以在保持抗HIV活性的同时用L-亮氨酸取代他汀类药物部分。

  DOI：

  10.1021/jm020069c
• 作为产物：
  描述：

  8-氨基辛酸 在 sodium hydroxide 、 氯化亚砜 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 24.0h， 生成 N-[3β-hydroxy-lup-20(29)-en-28-oyl]-8-aminooctanoic acid
  参考文献：
  名称：

  Betulinic Acid Derivatives:  A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry

  摘要：

  A novel series of omega-aminoalkanoic acid derivatives of betulinic acid were synthesized and evaluated for their activity against human immunodeficiency virus (HIV). The anti-HIV-1 activity of several members of this new series was found to be in the nanomolar range in CEM 4 and MT-4 cell cultures. The optimization of the omega-aminoalkanoic acid side chain is described. The presence of an amide function within the side chain was found important for optimal activity. RPR 103611 (14g), a statine derivative, was found to be inactive against HIV-1 protease, reverse transcriptase, and integrase as well as on gp120/CD4 binding. ''Time of addition'' experiments suggested interaction with an early step of HIV-1 replication. As syncytium formation, but not virus-cell binding, seems to be affected, betulinic acid derivatives are assumed to interact with the postbinding virus-cell fusion process.

  DOI：

  10.1021/jm950669u

文献信息

• Anti-AIDS Agents. 78. Design, Synthesis, Metabolic Stability Assessment, and Antiviral Evaluation of Novel Betulinic Acid Derivatives as Potent Anti-Human Immunodeficiency Virus (HIV) Agents
  作者：Keduo Qian、Donglei Yu、Chin-Ho Chen、Li Huang、Susan L. Morris-Natschke、Theodore J. Nitz、Karl Salzwedel、Mary Reddick、Graham P. Allaway、Kuo-Hsiung Lee

  DOI：10.1021/jm900136j

  日期：2009.5.28

  In a continuing study of potent anti-HIV agents, seventeen 28,30-disubstituted betulinic acid (BA, 1) derivatives and seven novel 3,28-disubstituted BA analogues were designed, synthesized, and evaluated for in vitro antiviral activity. Among them, compound 21 showed an improved solubility and equal anti-HIV potency (EC50 = 0.09 μM) when compared to HIV entry inhibitors 3b (IC9564, (3R,4S)-N′-[N-[

  在对有效抗 HIV 药物的持续研究中，设计、合成了 17 种 28,30-二取代桦木酸 (BA, 1 ) 衍生物和 7 种新型 3,28-二取代 BA 类似物，并评估了其体外抗病毒活性。其中，化合物21显示出改善的溶解度和等于抗HIV效力（EC 50相比HIV进入抑制剂时= 0.09μM）3B（IC9564，（3 - [R，4小号） - ñ ' - [ ñ - [3β羟基-lup-20(29)-en-28-oyl]-8-aminooctanoyl]-4-amino-3-hydroxy-6-methylheptanoic acid) 和4 (A43-D, [[ N -[3β- O-(3',3'-二甲基琥珀酰基)-lup-20(29)-en-28-oyl]-7-aminoheptyl]carbamoyl]methane)。使用环状仲胺形成 C-28 酰胺键显着增加了衍生物在汇集的人肝微粒体中的
• Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives
  作者：Li Huang、Phong Ho、Kuo-Hsiung Lee、Chin-Ho Chen

  DOI：10.1016/j.bmc.2005.11.016

  日期：2006.4

  Betulinic acid (BA) derivatives with a side chain at C-3 can inhibit HIV-1 maturation. On the other hand, BA derivatives with a side chain at C-28 can block HIV-1 entry. In order to combine the anti-maturation and anti-entry activities in a single molecule, new bi-functional BA derivatives containing side chains at C-3 and C-28 have been synthesized. The most potent compound ([[N-[3beta-O-(3',3'-d

  在C-3处带有侧链的桦木酸（BA）衍生物可以抑制HIV-1的成熟。另一方面，在C-28带有侧链的BA衍生物可以阻止HIV-1进入。为了在单个分子中结合抗成熟和抗进入活性，已经合成了在C-3和C-28处含有侧链的新的双功能BA衍生物。最有效的化合物（[[[N- [3beta-O-（3'，3'-二甲基琥珀酰基）-lup-20（29）-en-28-oyl] -7-氨基庚基] -carba moyl]甲烷抑制HIV -1在EC26为0.0026 microM时，效力至少是抗成熟铅化合物DSB或抗进入铅化合物IC9564的20倍。这种双功能BA衍生物对HIV的进入和成熟均具有活性。
• New Betulinic Acid Derivatives for Bevirimat-Resistant Human Immunodeficiency Virus Type-1
  作者：Zhao Dang、Phong Ho、Lei Zhu、Keduo Qian、Kuo-Hsiung Lee、Li Huang、Chin-Ho Chen

  DOI：10.1021/jm3016969

  日期：2013.3.14

  Bevirimat (1, BVM) is an anti-HIV agent that blocks HIV-1 replication by interfering with HIV-1 Gag-SP1 processing at a late stage of viral maturation. However, clinical trials of 1 have revealed a high baseline drug resistance that is attributed to naturally occurring polymorphisms in HIV-1 Gag. To overcome the drug resistance, 28 new derivatives of 1 were synthesized and tested against compound 1-resistant (BVM-R) HIV-1 variants. Among them, compound 6 exhibited much improved activity against several HIV-1 strains carrying BVM-R polymorphisms. Compound 6 was at least 20-fold more potent than 1 against the replication of NL4-3/V370A, which carries the most prevalent clinical BVM-R polymorphism in HIV-1 Gag-SP1. Thus, compound 6 merits further development as a potential anti-AIDS clinical trial candidate.
• Betulinic Acid Derivatives as Human Immunodeficiency Virus Type 2 (HIV-2) Inhibitors
  作者：Zhao Dang、Weihong Lai、Keduo Qian、Phong Ho、Kuo-Hsiung Lee、Chin-Ho Chen、Li Huang

  DOI：10.1021/jm9004253

  日期：2009.12.10

  We previously reported that [[N-[3 beta-hydroxyllup-20(29)-en-28-oyl]-7-aminoheptyl]carbamoyl]methane (A43D, 4) was a potent HIV-1 entry inhibitor. However, 4 was inactive against HIV-2 virus, suggesting the structural requirements for targeting these two retroviruses are different. In this study, a series of new betulinic acid derivatives were synthesized, and some of them displayed selective anti-HIV-2 activity at nanomolar concentrations. In comparison to compounds with anti-HIV-1 activity, a shorter C-28 side chain is required for optimal anti-HIV-2 activity.
• Betulinic Acid Derivatives:  A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry
  作者：Françoise Soler、Christèle Poujade、Michel Evers、Jean-Christophe Carry、Yvette Hénin、Anne Bousseau、Thierry Huet、Rudi Pauwels、Erik De Clercq、Jean-François Mayaux、Jean-Bernard Le Pecq、Norbert Dereu

  DOI：10.1021/jm950669u

  日期：1996.1.1

  A novel series of omega-aminoalkanoic acid derivatives of betulinic acid were synthesized and evaluated for their activity against human immunodeficiency virus (HIV). The anti-HIV-1 activity of several members of this new series was found to be in the nanomolar range in CEM 4 and MT-4 cell cultures. The optimization of the omega-aminoalkanoic acid side chain is described. The presence of an amide function within the side chain was found important for optimal activity. RPR 103611 (14g), a statine derivative, was found to be inactive against HIV-1 protease, reverse transcriptase, and integrase as well as on gp120/CD4 binding. ''Time of addition'' experiments suggested interaction with an early step of HIV-1 replication. As syncytium formation, but not virus-cell binding, seems to be affected, betulinic acid derivatives are assumed to interact with the postbinding virus-cell fusion process.